Skip to main content

Yeaman Kevin J's Form 4 filing

Dolby Laboratories, Inc. (DLB) · filed Jan 19, 2024

Accession no.
0000950170-24-005798
Filed
Jan 19, 2024
Trade date
Jan 17, 2024
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $754.1K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Yeaman Kevin JCIK 0001200469Director, Officer (President and CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jan 17, 2024Class A Common StockMOption exerciseAcquired+246$42.98+$10,573.0883,967Indirect
Jan 17, 2024Class A Common StockMOption exerciseAcquired+8,784$45.50+$399,67292,751Indirect
Jan 17, 2024Class A Common StockSSaleDisposed−9,030$83.51−$754,095.383,721Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jan 17, 2024Class A Common StockMOption exerciseDisposed−246$0.00$00Indirect
Jan 17, 2024Class A Common StockMOption exerciseDisposed−8,784$0.00$0185,615Indirect

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)